Sefika Pinar Senol
Overview
Explore the profile of Sefika Pinar Senol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurt S, Senol S, Yilmaz D, Bahceli O, Ozgen B, Sabrie Z, et al.
Cell Mol Biol (Noisy-le-grand)
. 2025 Jan;
70(12):52-58.
PMID: 39799497
Increasing evidence suggests that inhibition of receptor-interacting serine/threonine-protein kinase (RIPK) 1/RIPK3/mixed lineage kinase domain-like pseudokinase (MLKL) necrosome has protective effects in vivo models of painful conditions seen in humans associated...
2.
Horat M, Senol S, Bahceli O, Temiz-Resitoglu M, Sahan-Firat S, Sevim S, et al.
Cell Mol Biol (Noisy-le-grand)
. 2023 Nov;
69(10):9-16.
PMID: 37953590
Soluble epoxide hydrolase (sEH) inhibition has currently emerged as a therapeutic target in the treatment of various neuroinflammatory neurodegenerative diseases, including multiple sclerosis. Previously, we reported that treatment of mice...
3.
Yilmaz D, Senol S, Temiz-Resitoglu M, Sahan-Firat S, Tunctan B
Cell Mol Biol (Noisy-le-grand)
. 2023 Oct;
69(9):15-23.
PMID: 37807339
The nucleotide-binding oligomerization domain-like receptor X1 (NLRX1) has been associated with various anti-inflammatory mechanisms. We investigated whether the NLRX1 ligand docosahexaenoic acid (DHA) ameliorates lipopolysaccharide (LPS)-induced inflammatory hyperalgesia by interacting...
4.
Tunctan B, Senol S, Temiz-Resitoglu M, Yilmaz D, Guden D, Bahceli O, et al.
J Cardiovasc Pharmacol
. 2022 Mar;
80(2):276-293.
PMID: 35323151
The orphan receptor, G protein-coupled receptor (GPR) 75, which has been shown to mediate various effects of 20-hydroxyeicosatetraenoic acid (20-HETE), is considered as a therapeutic target in the treatment of...
5.
Guden D, Temiz-Resitoglu M, Senol S, Kibar D, Yilmaz S, Tunctan B, et al.
Can J Physiol Pharmacol
. 2021 Mar;
99(9):921-934.
PMID: 33641344
Neuroinflammation plays a critical role during sepsis triggered by microglial activation. Mammalian target of rapamycin (mTOR) has gained attraction in neuroinflammation, however, the mechanism remains unclear. Our goal was to...
6.
Cagli A, Senol S, Temiz-Resitoglu M, Guden D, Sari A, Sahan-Firat S, et al.
Drug Dev Res
. 2021 Feb;
82(6):815-825.
PMID: 33559150
Epoxyeicosatrienoic acids (EETs) have anti-inflammatory effects and soluble epoxide hydrolase (sEH) inhibition might be a useful therapeutic approach to manage inflammatory disorders. The purpose of the study was to investigate...
7.
Senol S, Temiz-Resitoglu M, Guden D, Sari A, Sahan-Firat S, Tunctan B
Neurochem Res
. 2021 Jan;
46(3):624-637.
PMID: 33389386
A selective RXR agonist, bexarotene, has been shown to have anti-inflammatory, anti-nociceptive, and neuroprotective effects in several models of numerous neurological diseases characterized by systemic inflammation. The mechanisms underlying these...
8.
Biliktu M, Senol S, Temiz-Resitoglu M, Guden D, Horat M, Sahan-Firat S, et al.
Inflammopharmacology
. 2020 Mar;
28(6):1509-1524.
PMID: 32128702
We aimed to determine the effect of soluble epoxide hydrolase (sEH) inhibition on chronic experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS), associated with changes in inflammasome-dependent...
9.
Tunctan B, Senol S, Temiz-Resitoglu M, Guden D, Sahan-Firat S, Falck J, et al.
Prostaglandins Other Lipid Mediat
. 2019 Oct;
145:106377.
PMID: 31586592
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Septic shock, the most common form of vasodilatory shock, is a subset of sepsis in which...
10.
Sahan-Firat S, Temiz-Resitoglu M, Guden D, Senol S, Sari A, Cil M, et al.
Clin Exp Pharmacol Physiol
. 2018 Oct;
46(2):173-182.
PMID: 30347478
We have previously demonstrated that the activation of the spleen tyrosine kinase (Syk)/inhibitory-κB (IκB)-α/nuclear factor-κB (NF-κB) p65 signalling pathway contributes to hypotension and inflammatory response in a rat models of...